Evidence map›Paper›PMID 42782865›Full record

SynthesisCurrent oncology (Toronto, Ont.)2026

Impact of Decision Aids for Shared Decision-Making for Patients with Early Stage Breast Cancer: A Systematic Review.

Serena Sdinami, Lorenzo Conti, Benedetta Capetti, Valeria Sebri, Paola Zagami, Roberto Grasso, Carmen Criscitiello, Giuseppe Curigliano, Gabriella Pravettoni

Abstract readSystematic Review
In one paragraph

Synthesis in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Serena SdinamiApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti, 435, 20141 Milan, Italy.ORCID 0009-0008-0058-2641
Lorenzo ContiApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti, 435, 20141 Milan, Italy.
Benedetta CapettiApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti, 435, 20141 Milan, Italy.ORCID 0000-0003-2050-9587
Valeria SebriApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti, 435, 20141 Milan, Italy.ORCID 0000-0002-1227-7336
Paola ZagamiDivision for New Drugs and Early Drugs Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-2687-6436
Roberto GrassoApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti, 435, 20141 Milan, Italy.ORCID 0000-0002-9699-9626
Carmen CriscitielloDepartment of Oncology and Hemato-Oncology, University of Milan, 20123 Milan, Italy.ORCID 0000-0001-9064-0113
Giuseppe CuriglianoDepartment of Oncology and Hemato-Oncology, University of Milan, 20123 Milan, Italy.ORCID 0000-0003-1781-2518
Gabriella PravettoniApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti, 435, 20141 Milan, Italy.

Funding

Eli Lilly and company a-36495
6 · The paper itself

Abstract

objectivesTo systematically review the evidence on the effectiveness of patient decision aids (PDAs) for women with early stage breast cancer, focusing on decision-making outcomes, psychological variables, and quality of life.

methodsA systematic review was conducted in accordance with PRISMA guidelines. PUBMED, EMBASE and SCOPUS databases were searched to identify quantitative, qualitative and mixed-methods studies evaluating PDAs designed to support treatment decision-making in women with early stage breast cancer. Eligible studies included randomized controlled trials, quantitative, qualitative and mixed-methods studies. Outcomes of interest included knowledge, decisional conflict, Shared Decision-Making (SDM), anxiety, depression, and quality of life. Special focus has been given to lower Socio-Economic Status (SES) and lower literacy populations.

resultsTwenty-six studies (5174 participants) met inclusion criteria. PDAs were associated with reduced decisional conflict (6 of 7 studies), improved satisfaction with the decision or decision-making process (4 studies), and enhanced knowledge (4 of 8 studies showing statistically significant improvement). No consistent adverse effects on anxiety or depression were observed. Ten studies focused on lower SES or low-literacy populations, highlighting the effectiveness of pictorial and simplified PDAs in improving knowledge, SDM, and reducing decisional regret. Qualitative findings indicated high acceptability but identified barriers related to timing and institutional implementation.

conclusionsPDAs for women with early stage breast cancer enhance knowledge and support informed, value-congruent treatment decisions. However, evidence regarding their impact on psychological well-being and long-term quality of life remains inconclusive. Further research should also address institutional implementation policies.

Indexed as

Breast NeoplasmsDecision Making, SharedDecision Support TechniquesDecision MakingFemaleHumansNeoplasm StagingPatient ParticipationQuality of Lifedecision qualityearly stage breast cancerhealth literacyimplementationpatient decision aidshared decision-making

Identifiers

PMID42782865
PMCPMC13605262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.